TABLE 1

Summary statistics of demographic dataa

TrialNo. of patientsMedian wt (kg) (range)Median ht (cm) (range)Median age (yr) (range)No. of male patients
I7775.3 (61–97.7)176.7 (161–190)42.5 (19–55)71
II5076.5 (50.9–112.4)174.5 (138–200)41.5 (19–63)42
III13973.5 (64–140)164 (145–186)61 (19–90)21
  • a Summary statistics of demographic data from healthy volunteers receiving oral (trial I) or intravenous (trial II) administrations and from patients receiving intravenous administrations (trial III) of finafloxacin. Medians and ranges (minimum to maximum) are presented.